- Home
- KSS vs XNCR Comparison
KSS vs XNCR Comparison
Compare KSS & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KSS | XNCR |
|---|---|---|
| Founded | 1962 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 1995 | 2013 |
Fundamental Metrics
Financial Performance| Metric | KSS | XNCR |
|---|---|---|
| Price | $17.67 | $29.30 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 15 | 9 |
| Target Price | $15.31 | ★ $22.33 |
| AVG Volume (30 Days) | ★ 3.0M | 1.1M |
| Earning Date | 05-28-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.58% | N/A |
| EPS Growth | ★ 142.86 | 65.36 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $125,576,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.21 | $4.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 13.65 |
| 52 Week Low | $11.38 | $7.80 |
| 52 Week High | $25.22 | $29.42 |
Technical Indicators
Market Signals| Indicator | KSS | XNCR |
|---|---|---|
| Relative Strength Index (RSI) | 45.61 | 83.18 |
| Support Level | $17.06 | $11.20 |
| Resistance Level | $20.09 | N/A |
| Average True Range (ATR) | 0.84 | 1.44 |
| MACD | -0.24 | 0.58 |
| Stochastic Oscillator | 32.46 | 100.00 |
Price Performance
Historical ComparisonAbout KSS Kohl's Corporation
Kohl's is the second-largest traditional US department store company by sales. It has about 1,150 stores in 49 states and offers moderately priced private-label (31% of 2025 sales) and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most (about 80%) of its stores are in strip centers. Kohl's also has a large digital sales operation (29% of 2025 sales). Women's apparel is the retailer's largest category, having generated 24% of its 2025 sales. Kohl's is headquartered in Menomonee Falls, Wisconsin, and was founded in 1962.
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.